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Background: Vestibular migraine (VM) is complex disorder consisting of episodes of
migraine and vertigo with an estimated prevalence of 1–3%. As migraine, it is considered
that VM has genetic predisposition; however, evidence to support a genetic contribution
has not been critically appraised.
Objective: The aim of this systematic review is to assess available evidence in scientific
publications to determine the role of inheritance in VM.
Methods: After performing the quality assessment of the retrieved records, 31 studies
were included (24 epidemiological reports and 7 genetic association studies in families or
case-control in candidate genes). We gathered data about prevalence of VM in different
populations and in families, and also about the genetic findings reported. In addition,
other variables were considered to assess the heritability of VM, such as the ancestry,
the age of onset or the familial history of vertigo and migraine.
Results: The estimated prevalence of VM was different between black (3.13%), white
(2.64%) and Asian (1.07%) ethnicities. The reported prevalence of VM inmigraine patients
is higher in European countries (21%) than in Asian countries (10%). Moreover, the
prevalence of the migraine-vertigo association in families is 4–10 times higher than
the prevalence reported in the general population (sibling recurrence risk ratio λs =
4.31–10.42). We also found that the age of onset is lower in patients with simultaneous
onset of symptoms and in those who have familial history for migraine and/or vertigo,
suggesting anticipation. Although some genetic studies have reported few allelic variants
associated to MV, replication studies are needed to validate these results.
Conclusions: The available evidence to support heritability in VM is limited. Variability in
prevalence depending on ethnicity and geographic location suggests a combined genetic
and environmental contribution to VM. However, the familial aggregation observed in VM
support genetic and shared familial environmental effects that remarks the necessity of
twins and adoptees-based epidemiological studies to estimate its heritability.
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INTRODUCTION
Migraine is a complex multifactorial disorder characterized by
headache attacks associated with a constellation of neurological
symptoms. In approximately one-third of patients, headaches
are preceded by transient focal sensorial symptoms, so-called
auras, involving visual and hearing systems. Genetic factors
contribute to the clinical spectrum of migraine and multiple
common variants have been associated with migraine with and
without aura (Sutherland andGriffiths, 2017; de Boer et al., 2019).
The diagnostic criteria of migraine were standardized according
to the International Headache Society (Headache Classification
Committee of the International Headache Society, 2018).
Epidemiological evidence supports that familial aggregation
with an early disease onset, particularly for the aura subtype,
indicating a higher genetic susceptibility in migraine with aura
(Russell et al., 1996; Ulrich et al., 1999;Mulder et al., 2003; Stewart
et al., 2006).
Vestibular migraine (VM) consist of a subgroup of patients
with migraine where the sensorial symptoms involve the
vestibular system. VM is characterized by recurrent episodes of
vertigo, a current or past history of migraine and simultaneous
occurrence of both symptoms during crisis (Li et al., 2019). VM is
one of the most common causes of recurrent vertigo. Prevalence
studies have described MV as a frequent disease (0.9–2.7%), with
variations in the frequency according to the population of study
(Neuhauser et al., 2006; von Brevern et al., 2007; Formeister et al.,
2018). However, VM is underdiagnosed, due to variability and
overlap of symptoms with other causes of vertigo and to normal
neurological examination and neuroimaging (Li et al., 2019).
The diagnostic criteria for VM were jointly developed by the
Barany Society and the International Headache Society in 2012
(Lempert et al., 2012), and they differentiate probable and definite
VM. Criteria for definite VM were included in the appendix of
the 3rd edition of the International Classification of Headache
Disorders (ICHD-III), one step forward to consider VM as an
independent entity (Headache Classification Committee of the
International Headache Society, 2018).
Migraine is a complex and multifactorial disorder with a large
genetic component (Sutherland and Griffiths, 2017). Therefore,
VM could also present a genetic predisposition (Knezevic et al.,
2018; Rainero et al., 2019).
Familial clustering in VM has been occasionally observed,
supporting the hypothesis of a genetic contribution to VM
(Espinosa-Sanchez and Lopez-Escamez, 2015). Some studies
reported families with an autosomal dominant inheritance with a
moderate to high penetrance; however, no causative mutations
have been found (Kim et al., 1998; von Brevern et al., 2006).
Moreover, some loci segregating VM have been identified by
linkage analysis in some few families with affected individuals
in 22q12 (Lee et al., 2006) and 5q35 (Bahmad et al., 2009).
These results suggest polygenic inheritance for VM; however,
evidence to support a genetic contribution has not been critically
appraised, and more research in this area is needed.
The aim of this systematic review is to assess available evidence
in scientific publications to determine the role of inheritance
in VM. So, we gathered information about the prevalence of
VM in different populations, including family studies and twin




This review has followed the Preferred Reported Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines
(Moher et al., 2009) (Supplementary Table 1).
According to the methodology for systematic reviews,
the issues related to the PICO question are listed below
and the studies have been selected according to the
following characteristics:
- Participants: Patients diagnosed with VM.
- Intervention: Measurement of prevalence of the disease,
estimation of familial aggregation, estimation of concordance
in monozygotic/dizygotic twins, measurement of the presence
of certain genes or loci, measurement of other demographic
characteristics (age of onset of symptoms, familial history of
migraine, vertigo or the vertigo-headache association).
- Control: Controlled and uncontrolled studies.
- Main results: Variation in the prevalence of the disease among
different populations, families and twins compared to the
general population.
- Secondary results: Reported associations with certain genes
or loci; variation in the prevalence of other demographic
characteristics (age of onset or family history).
- Study design: Case-control studies, family studies, twin
concordance studies, cross-sectional studies and case series.
Search Strategy
The article search was performed on May 23, 2020 in the
PubMed and Scopus databases, with the following combination
of keywords: (“vestibular migraine” OR “migrainous vertigo”
OR “migraine associated vertigo” OR “migraine related vertigo”)
AND (“epidemiology” OR “prevalence” OR “inheritance” OR
“heritage” OR “heritability” OR “genes” OR “genetics” OR
“families” OR “familial” OR “twins”). The search was limited
to articles published in the last 25 years. Additional records
identified through the list of references or other sources were
also included.
Exclusion Criteria
Records that met the following characteristics were excluded
from the review:
- Animal studies.
- Studies in child population.
- Articles published in languages other than English or Spanish.
Data Collected
Two independent reviewers (APT, PPC) analyzed the scientific
papers that met the selection criteria. Each article was reviewed
to extract the relevant data for the purpose of this work. The
main data that were extracted from the studies were those
referring to indicators of heritability, since the main objective
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of this review is to assess whether VM is a disease that has a
genetic contribution. These heritability criteria in multifactorial
disorders are estimated by comparing the variation of the
prevalence of the disease among population with different ethnic
background and by familial aggregation studies calculating the
sibling recurrence risk ratio (λs) using the Falconer formula
(Wickramaratne and Hodge, 2001).
The following information was also collected from descriptive
and genetic studies: first author and year of publication, country,
study design, main objective, sample size, MV diagnostic criteria,
ancestry, sex of patients with VM, mean age of patients with VM
andmean age of VM onset. From descriptive studies information
on VM prevalence, target population, and family history of MV
was also extracted.
Data Synthesis
Information on the prevalence of VM have been collected in
epidemiological studies. Mean values and standard deviation
have been calculated for the age of onset of migraine and vertigo.
Prevalence of VM in families was estimated from different studies
and pooled to calculate the recurrence risk among siblings (λs).
Statistical analyses were performed using Microsoft Excel and
SPPS software.
Quality Assessment
The quality of each study has been assessed through the Cochrane
Collaboration Tool (Higgins et al., 2019) and the risk of bias
was summarized in Supplementary Table 2. Furthermore, the
quality of genetic studies has also been evaluated according to the
criteria defined to assess genetic studies in quantitative traits with
extreme phenotype (Amanat et al., 2020).
RESULTS
Thirty-one studies with a total sample size of 41,127 individuals
were finally included in this revision, according to the eligibility
criteria. A flowchart detailing the selection of studies is included
in Figure 1.
Cross-Sectional Studies and Case Series
Twenty-four descriptive epidemiological studies were included
(16 cross-sectional studies, 5 case series, and 3 familial
studies) (Supplementary Table 3). These studies estimated the
prevalence of VM in different populations, geographical areas
or families and reported clinical and demographic features of
this disease. Five studies were population-based, while the rest
were hospital-based.
Only 5 studies mentioned the ancestry and 3 of them included
data about the prevalence of VM. An earlier onset of the disease
was found in families when they were compared to non-familiar
VM patients.
A female preponderance was observed in VM, although four
studies did not report this information. Nineteen studies reported
the mean age of patients with VM, however, only 11 described
the age at VM onset. Thus, familial history of VM patients was
detailed in seven studies.
FIGURE 1 | Selection of studies.
Genetic Studies
Seven genetic studies were included (3 case-control studies and 4
genetic linkage analysis in families) (Table 1). The main purpose
of these studies was to findmutations or loci in families associated
with the disease. One of the case-control studies reported
a significant association of the allelic variant rs770963777 in
the HTR6 gene with VM in a small cohort of Han Chinese
descendants. Two of the studies reported significant associations
of VMwith certain genome regions: a locus in chromosome 5q35,
and the PROGINS variant of the PRG gene, respectively. Another
study found significant association between chromosome 22q12
and benign recurrent vertigo, which was a common diagnosis
established for patients with migraine and episodic vertigo before
the VM diagnostic criteria were established.
Three studies reported the ancestry, specifically Han Chinese
in one of the studies, Caucasian in another one and German,
Bosnian and Turkish in the last one. Female preponderance was
also observed in all genetic studies.
Prevalence of VM According to the
Geographic Area or Ancestry
Two population-based studies estimated the prevalence of VM in
the general population, ranging from 0.89 to 2.70% in Germany
and US, respectively. However, most studies were hospital-based
and the authors estimated the prevalence of VM in migraine
patients and in outpatient clinics, showing some differences. Five
studies used the Barany Society diagnostic criteria for VM, and




























TABLE 1 | Summary of the six genetic studies in patients with vestibular migraine.








Mean age of VM
onset (years)
Wu et al. (2020) China Case-control To investigate the
association of rs770963777










analysis in one family
using microsatellite
markers





29 Non-significant results - ICHD-I: migraine








analysis in one family
using microsatellite
markers
To map the genetic locus for
familial VM and to define the
progression of the disease
in one family
23 Significant association
of VM with a region of
chromosome 5q35
Neuhauser et al. Not available 50% 60.7 ± 20.6 - 12± 4.7
(migraine)
- 39.2 ± 6.2
(vertigo)
Lee et al. (2008) USA Genetic linkage
analysis in one family
To analyze phenotypic and
genetic features of a family
with VM in order to assess
its inheritance pattern.






- ad hoc criteria:
VM
Not available 87.5% 47.6 ± 15.4 - 14.7 ± 6
(migraine)
- 36.2 ± 9.1
(vertigo)




Lee et al. (2007) USA Case-control To test the association of
female hormonal genes








- ad hoc clinical
criteria: vertigo
Caucasian 83.4% Not available Not available
von Brevern et al.
(2006)
USA/Germany Case-control To test whether mutations in
CACNA1A, ATP1A2,
SCN1A and CACNB4
confer susceptibility to VM
- 14MV
- 46 controls





64.3% 50 ± 11.1 - 21.3 ± 7.5
(migraine)
- 37.9 ± 14.4
(vertigo)




Lee et al. (2006) USA Genome-wide linkage
analysis in families
To genetically define BRV
and its association with
migraine.






- IHS criteria for
migraine
- ad hoc clinical
criteria for vertigo
Not available 84.4% Not available Not available
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TABLE 2 | Prevalence of vestibular migraine depending on geographic area and target population (outpatients clinics or hospital-based studies).




Diagnostic criteria Prevalence of VM
Power et al. (2018) Oceania Australia Outpatients in a
balance disorders
clinic
90 Barany/IHS 41% definite and
probable VM
Yollu et al. (2017) Europe Turkey Patients with
migraine
100 Barany/IHS 21% definite VM
Hazzaa and El
Mowafy (2016)
Africa Egypt Outpatients in a
dizziness clinic
446 Barany/IHS 22% definite VM
Akdal et al. (2015) Europe Turkey Patients with
migraine
871 - ICHD-II for migraine.







Akdal et al. (2013) Europe Turkey Patients with
migraine
1,880 - ICHD-II for migraine.










Africa South Africa Patients visiting a
general
practitioner
717 Neuhauser et al. 1.67% (definite and
probable VM)
Uneri (2004) Europe Turkey Patients with
BPPV
476 ICHD-I for migraine 54.8% migraine
Van Ombergen
et al. (2015)
Europe Belgium Patients attending
an ORL clinic
407 Barany/IHS - 4.3% definite VM
- 5.6% probable VM
Vuković et al.
(2007)
Europe Croatia Patients with
migraine
327 Neuhauser et al. 23.2% definite VM
Neuhauser et al.
(2001)










Neuhauser et al. - 9% definite VM in
patients with migraine
- 7% definite VM in
patients attending a
dizziness clinic
Cho et al. (2016) Asia South Korea Patients with
migraine
631 Barany/IHS - 10.3% definite VM
- 2,5% probable VM
Tungvachirakul
et al. (2014)
Asia Thailand Patients attending
a neurotology
clinic
167 Neuhauser et al. 34.7% definite VM
VM, Vestibular Migraine; IHS, International Headache Society; ICHD, International Classification of Headache Disorders; BPPV, Benign Paroxysmal Positional Vertigo.
showed a prevalence of VM ranging from 4.3% in Belgium to 22%
in Egypt (Table 2).
One population-based study performed in US described that
13.9% of VM patients were black, while 79.8% of VM patients
were white, which results in a significant difference. After the
analysis of the results from this population-based survey, we
calculated the prevalence of VM for each ethnicity, resulting
in a VM prevalence of 3.13% in African descendants, 2.64% in
Europeans and 1.07% in Asian descendent population.
Familial Aggregation
Three studies reported that the migraine-vertigo association was
more frequent in siblings of patients with VM than in the
general population.
On the other hand, some cross-sectional and case series
studies described a familial history of migraine, vertigo or both
among VM patients. So, a familial history of migraine was
reported in 70% of VM patients and 21.4% of VM patients had
a familial history of VM.
The sibling recurrence risk ratio (λs) for the migraine-
vertigo association was calculated by comparing the prevalence
of this association in families with that prevalence in the
general population, to assess the familial aggregation for
VM (Table 3). Our results also showed a moderate familial
aggregation (λs = 4.31–10.42).
Age of VM Onset
We compared the age of VM onset in different studies,
particularly, the age of migraine onset, the age of vertigo onset
and the simultaneous onset of vertigo and migraine, including a
brief analysis on sex distribution (Table 4). So, we found that the
mean age of onset in patients with simultaneous presentation of
vertigo and migraine was 22.7± 10.4 years; however, for patients
with a metachronic presentation of symptoms, the mean age of
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TABLE 3 | Prevalence of migraine-vertigo association in families and sibling recurrence risk (λs).












29 4 15 26.67 8.33
Bahmad et al. (2009) 23 4 12 33.33 10.42
Cha et al. (2008) 69 4 29 13.79 4.31
Lee et al. (2008) 46 2 14 14.29 4.46
Lee et al. (2006) 257 13 57 22.81 7.13
Oh et al. (2001) 287 20 68 29.41 9.19
Oliveira et al. (1997) 19 5 18 27.78 8.68
Total 730 52 213 24.41 7.63
*Studies based on Barany Society diagnostic criteria for VM.
TABLE 4 | Sex distribution and age of onset (mean ± standard deviation) of migraine, vertigo, and patients with simultaneous onset of both symptoms.
References Number of patients with
VM and non-
simultaneous onset of






Number of patients with
VM and simultaneous





*Beh et al. (2019) 129 – 44.3 ± 13.7 – –
*Peddareddygari et al.
(2019)
10 (9/1) – 10.5 ± 4 – –
Teggi et al. (2018) 260 21.8 ± 9 37.4 ± 13.1 19 19.8 ± 2.1
Martínez et al. (2017) 14 (14/0) 16.3 ± 8.2 31.7 ± 11.8 27 24 ± 12
*Cohen et al. (2011) 147 30.7 38.7 – –
Bahmad et al. (2009) 6 (2/4) 12 ± 4.7 39.2 ± 6.2 – –
Lee et al. (2008) 6 (5/1) 14.7 ± 6 36.2 ± 9.1 2 13.5 ± 9.2
*Vuković et al. (2007) 169 (migraine with
vestibular
symptoms)
– 25.3 – –
von Brevern et al.
(2006)
11 (6/5) 21.3 ± 7.5 37.9 ± 14.4 3 35.3 ± 13.4
*Neuhauser et al.
(2001)
33 22 ± 11 35 ± 14 – –
*Oh et al. (2001) 20 – 34.15 ± 16.9 – –
Oliveira et al. (1997) 8 (5/3) 15.5 ± 10.1 – – –
Female total 41 15, 2+/-7, 4 33, 7+/- 15, 9 21 24, 8+/- 12, 8
Male total 14 19, 9+/-10, 1 37, 5+/-14, 3 11 23, 6+/-13, 3
Total 813 24 ± 8.9 35.6 ± 12.4 51 22.7 ± 10.4
VM, Vestibular Migraine. *These studies do not report data on simultaneous age of onset; therefore, they were included in the “patients with non-simultaneous onset” category.
onset for migraine was 24 ± 8.9 years, and 35.6 ± 12.4 year
for vertigo.
To sum up, we observed that 6 studies recorded data about
audiological symptoms in VM. The prevalence and distribution
of these audiological symptoms in VM is shown in Table 5.
DISCUSSION
The association between migraine and vertigo has been known
for a long time; however, it has not been considered as an
independent entity until the last decade (56). The current
diagnostic criteria were published in 2012 (Lempert et al., 2012),
therefore, only 8 of the studies included in this revision applied
these criteria for the diagnosis of VM. The criteria proposed by
Neuhauser et al. (2001) were reported in 8 of the studies, and in
the rest of the publications, the authors used ICHD criteria for
migraine and ad-hoc clinical criteria for vertigo. One of the family
studies did not report any diagnostic criteria, but later this family
was reported as familial VM.
There are several evidence to support heritability in complex
traits such as vestibular disorders: (a) differences in the
prevalence of the condition according to the ethnic background;
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TABLE 5 | Prevalence of audiological symptoms in patients with VM.
References N Audiological symptoms reported Number of patients with
otological symptoms
Prevalence
Teggi et al. (2018) 252 Tinnitus (during vertigo attacks) 27 0.11
Ear fullness (during vertigo attacks) 22 0.09
Hearing loss (during vertigo attacks) 10 0.04
Yollu et al. (2017) 21 Sensorineural hearing loss (SNHL)
according to average hearing threshold
2 0.09
SNHL acc. to low frequency 6 0.28
SNHL acc. to high frequency 11 0.52
Van Ombergen et al. (2015) 65 Tinnitus 35 0.54
Decreased hearing 3 0.05
Hearing loss 5 0.25
Cha et al. (2008) (families
study)
20 Migraine and MD symptoms (migraine/MD) 19 0.13
Lee et al. (2007) 150 Migraine and MD symptoms (migraine/MD) 19 0.13
Neuhauser et al. (2006) 33 Cochlear symptoms (during vertigo
attacks)
12 0.36
Tinnitus (during vertigo attacks) 5 0.15
Aural fullness (during vertigo attacks) 5 0.15
Hearing loss (during vertigo attacks) 3 0.09
Total 541 Hearing loss 46 0.085
350 Tinnitus 67 0.191
(b) familial aggregation with early onset and anticipation; and
(c) high concordance of the phenotype in monozygotic twins
and adoptees with biological parents when they are compared
with dizygotic twins or adoptive parents, respectively (Gallego-
Martinez et al., 2018).
The population-based study from Formeister et al. (2018)
showed a higher prevalence of VM in African American or
Europeans than in Asian descendent population, suggesting a
possible genetic contribution. It should be interesting to compare
the prevalence of VM in East Asia in a large cohort with the Asian
American descendent to assess the environmental effect on VM.
Moreover, the prevalence of VM in migraine patients seems
to be higher in European countries (23% in Croatia, 21% in
Turkey) (Vuković et al., 2007; Yollu et al., 2017) than in Asian
countries (10% in South Korea) (Cho et al., 2016). However, the
diagnosis of VM in neurotology clinics shows a great variation
ranging from a 7% reported in Germany (Neuhauser et al.,
2001), 22% in Egypt (Hazzaa and El Mowafy, 2016) to 41% in
Australia (Power et al., 2018). These data suggest differences
in the diagnostic criteria used rather than ethnic differences in
VM and evidence that population-based studies are needed to
estimate the prevalence of VM.
Familial aggregation is usually reported in rare diseases, and
suggests a combined effect of genetic and environmental factors
(Requena et al., 2014a). This type of studies compares the
prevalence of a disease in individuals of the same generation
within a family with the prevalence of that disease in general
population. In order to do this, the sibling recurrence risk ratio
(λs) is calculated. That proportion allows us to know how many
times the disease is more frequent between the siblings of the
affected individual, as compared with the general population.
Our systematic review show that familial studies (Oliveira et al.,
1997; Oh et al., 2001; Lee et al., 2006, 2008; Cha et al., 2008;
Bahmad et al., 2009; Peddareddygari et al., 2019) showed a
higher prevalence of the migraine-vertigo association than the
observed prevalence of that association in the general population
(3.2%) (Neuhauser et al., 2001), and also higher than the 2.7%
prevalence of VM in general population (Formeister et al., 2018).
We calculated λs for the migraine-vertigo association, which
resulted in a risk ranging between 4–10 times higher than in
general population.
Most of the studies included in this review reported
information about age of onset of migraine and vertigo. Some
of them described a significantly lower age of onset in patients
with VM, as compared with controls affected either by migraine
or vertigo (Vuković et al., 2007; Akdal et al., 2013). By comparing
the age of VM onset in several studies, we found that there was
an earlier onset of symptoms in those patients with simultaneous
presentation of migraine and vertigo, as compared with those
with metachronic onset of symptoms.
Early and simultaneous onset of symptoms observed in
familial VM suggests genetic anticipation, a phenomenon of
progression of severity of an inherited disorder in successive
generations frequently found in neurological disorders and
associated with expansion of nucleotide repeats (Carpenter,
1994). Teggi et al. (2018) reported a significantly lower age of
migraine onset in patients with a familial history of migraine
or VM, as compared with those without it. These results were
also reported in some of the included familial studies (Lee
et al., 2008; Bahmad et al., 2009; Peddareddygari et al., 2019),
Frontiers in Genetics | www.frontiersin.org 7 August 2020 | Volume 11 | Article 954
Paz-Tamayo et al. Heritability in Vestibular Migraine
in which age of migraine onset seems to be lower than in
non-familial cases.
The genetic association studies retrieved have reported allelic
variants in the HTR6 and PRG genes associated with VM (Lee
et al., 2007; Wu et al., 2020). Replication studies are needed to
validate these results.
The genetic contribution to vestibular diseases, including VM
is largely unknown (Requena et al., 2014b; Gallego-Martinez
et al., 2018). The application of high throughput sequencing
technologies in multiplex families with deep phenotyping will
target candidate genes and clarify disease mechanisms and
facilitate the genetic diagnosis of VM in clinical practice (Di Resta
and Ferrari, 2018; Prodan Žitnik et al., 2018).
Limitations of This Study
Most of the genetic studies included in this revision are based on
linkage analysis of multicase families. The majority of them were
published more than a decade ago and were performed before
the development of high-throughput DNA massively parallel
sequencing technology. Only two of them found 2 loci associated
with VM, but none of them found the causal mutations.
The current diagnostic criteria for VM were published in
2012, so previous studies applied different probably broader
criteria. This variability in the diagnostic criteria is a selection
bias that might influence the estimated prevalence and therefore,
could limit the comparability between studies. Moreover, the
number of studies analyzing VM heritability could be considered
low, so few of them share the same variables, resulting in a
limited comparability.
Future Perspectives
This systematic review provides some evidences to support
a genetic contribution in VM, including familial aggregation.
There is a need to perform twins and adoptees studies to
estimate heritability in VM. Therefore, whole genome sequencing
studies in multicase families are needed to find genetic variants
conferring susceptibility to this disease.
CONCLUSIONS
1. Clinical studies seem to report differences in the prevalence of
VM according to the ethnic origin and country.
2. Family aggregation studies show a higher prevalence of
migraine and vertigo in families compared to general
population, with a moderate risk of recurrence among siblings
and possible anticipation.
3. Since there are no twins studies published, there is a need to
perform such studies to estimate heritability in VM.
AUTHOR CONTRIBUTIONS
JL-E conceived the study design and develop the scientific
arguments. AP-T and PP-C performed literature search, quality
assessment of the studies, and interpretation of data. All authors
drafted the manuscript and revised the final version.
ACKNOWLEDGMENTS
The authors wish to thank Juan Manuel Espinosa Sánchez MD at
Hospital Universitario Virgen de las Nieves for his support in the
literature search.
SUPPLEMENTARY MATERIAL




Akdal, G., Baykan, B., Ertaş, M., Zarifoğlu, M., Karli, N., Saip, S.,
et al. (2015). Population-based study of vestibular symptoms in
migraineurs. Acta Otolariyngol. 135, 435–439. doi: 10.3109/00016489.2014.
969382
Akdal, G., Ozge, A., and Ergör, G. (2013). The prevalence of vestibular
symptoms in migraine or tension-type headache. J. Vestib. Res. 23, 101–106.
doi: 10.3233/VES-130477
Amanat, S., Requena, T., and Lopez-Escamez, J. A. (2020). A systematic review of
extreme phenotype strategies to search for rare variants in genetic studies of
complex disorders. Genes (in press).
Bahmad, F., DePalma, S. R., Merchant, S. N., Bezerra, R. L., Oliveira, C. A.,
Seidman, C. E., et al. (2009). Locus for familial migrainous vertigo disease
maps to chromosome 5q35. Ann. Otol. Rhinol. Laryngol. 118, 670–676.
doi: 10.1177/000348940911800912
Beh, S., Masrour, S., Smith, S., and Friedman, D. (2019). The spectrum of vestibular
migraine: clinical features, triggers and examination findings. Headache 59,
727–740. doi: 10.1111/head.13484
Carpenter, N. J. (1994). Genetic anticipation. expanding tandem repeats. Neurol.
Clin. 12, 683–697. doi: 10.1016/S0733-8619(18)30071-9
Cha, Y. H., Kane, M. J., and Baloh, R. W. (2008). Familial clustering of
migraine, episodic vertigo, Ménière’s disease. Otol. Neurotol. 29, 93–96.
doi: 10.1097/mao.0b013e31815c2abb
Cho, S. J., Kim, B. K., Kim, B. S., Kim, J. M., Kim, S. K., Moon, H. S., et al. (2016).
Vestibular migraine in multicenter neurology clinics according to the appendix
criteria in the third beta edition of the international classification of headache
disorders. Cephalalgia 36, 454–462. doi: 10.1177/0333102415597890
Cohen, J., Bigal, M., and Newman, L. (2011). Migraine and vestibular symptoms
- identifying clinical features that predict “vestibular migraine”. Headache 51,
1393–1397. doi: 10.1111/j.1526-4610.2011.01934.x
de Boer, I., van den Maagdenberg, A. M. J. M., and Terwindt, G. M.
(2019). Advance in genetics of migraine. Curr. Opin. Neurol. 32, 413–421.
doi: 10.1097/WCO.0000000000000687
Di Resta, C., and Ferrari, M. (2018). Next generation sequencing: from research
area to clinical practice. EJIFCC 29, 215–220.
Espinosa-Sanchez, J. M., and Lopez-Escamez, J. A. (2015). New insights
into pathophysiology of vestibular migraine. Front. Neurol. 6:12.
doi: 10.3389/fneur.2015.00012
Formeister, E. J., Rizk, H. G., Kohn, M. A., and Sharon, J. D. (2018). The
Epidemiology of vestibular migraine: a population-based survey study. Otol.
Neurotol. 39, 1037–1044. doi: 10.1097/MAO.0000000000001900
Gallego-Martinez, A., Espinosa-Sanchez, J. M., and Lopez-Escamez, J. A. (2018).
Genetic contribution to vestibular diseases. J. Neurol. 265(Suppl. 1), 29–34.
doi: 10.1007/s00415-018-8842-7
Hazzaa, N., and El Mowafy, S. S. (2016). Clinical features of vestibular
migraine in Egypt. Egypt. J. Ear Nose Throat Allied Sci. 17, 17–21.
doi: 10.1016/j.ejenta.2015.12.002
Frontiers in Genetics | www.frontiersin.org 8 August 2020 | Volume 11 | Article 954
Paz-Tamayo et al. Heritability in Vestibular Migraine
Headache Classification Committee of the International Headache Society (2018).
(IHS) The international classification of headache disorders, 3rd edition.
Cephalalgia. 38, 1–211. doi: 10.1177/0333102417738202
Higgins, J., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M., et al.
(2019). Cochrane Handbook for Systematic Reviews of Interventions version
6.0 Cochrane. Chichester, UK: John Wiley & Sons.
Jay-du Preez, T., and van Papendorp, D. (2011). Migraine-associated vertigo and
dizziness as presenting complaint in a private general medical practice. South
Afr. Family Pract. 53, 165–169. doi: 10.1080/20786204.2011.10874079
Kim, J. S., Yue, Q., Jen, J. C., Nelson, S. F., and Baloh, R. W. (1998). Familial
migraine with vertigo: no mutations found in CACNA1A. Am. J. Med.
Genet. 79, 148–151. doi: 10.1002/(SICI)1096-8628(19980901)79:2<148::AID-
AJMG11>3.0.CO;2-J
Knezevic, N. N., Tverdohleb, T., Knezevic, I., and Candido, K. D. (2018). The role
of genetic polymorphisms in chronic pain patients. Int. J. Mol. Sci. 19:1707.
doi: 10.3390/ijms19061707
Lee, H., Jen, J. C., Cha, Y. H., Nelson, S. F., and Baloh, R.W. (2008). Phenotypic and
genetic analysis of a large family withmigraine-associated vertigo.Headache 48,
1460–1467. doi: 10.1111/j.1526-4610.2007.01002.x
Lee, H., Jen, J. C., Wang, H., Chen, Z., Mamsa, H., Sabatti, C., et al. (2006).
A genome-wide linkage scan of familial benign recurrent vertigo: linkage
to 22q12 with evidence of heterogeneity. Hum. Mol. Genet. 15, 251–258.
doi: 10.1093/hmg/ddi441
Lee, H., Sininger, L., Jen, J. C., Cha, Y. H., Baloh, R. W., and Nelson, S. F.
(2007). Association of progesterone receptor with migraine-associated vertigo.
Neurogenetics 8, 195–200. doi: 10.1007/s10048-007-0091-3
Lempert, T., Olesen, J., Furman, J., Waterston, J., Seemungal, B., Carey, J., et al.
(2012). Vestibular migraine: diagnostic criteria. J. Vestib. Res. 22, 167–172.
doi: 10.3233/VES-2012-0453
Li, V., McArdle, H., and Trip, S. A. (2019). Vestibular migraine. BMJ 366:l4213.
doi: 10.1136/bmj.l4213
Martínez, E., Ruiz-Piñero, M., de Lera, M., Barón, J., Pedraza, M., and Guerrero-
Peral, A. (2017). Clinical characteristics of vestibular migraine: considerations
in a series of 41 patients. Rev. Neurol. 64, 1–6. doi: 10.33588/rn.6401.2016164
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., and Group, P. (2009). Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
statement. J. Clin. Epidemiol. 62, 1006–1012. doi: 10.1016/j.jclinepi.2009.
06.005
Mulder, E. J., Van Baal, C., Gaist, D., Kallela, M., Kaprio, J., Svensson, D. A.,
et al. (2003). Genetic and environmental influences on migraine: a twin
study across six countries. Twin Res. 6, 422–431. doi: 10.1375/1369052037703
26420
Neuhauser, H., Leopold, M., von Brevern, M., Arnold, G., and Lempert, T. (2001).
The interrelations of migraine, vertigo, migrainous vertigo. Neurology 56,
436–441. doi: 10.1212/WNL.56.4.436
Neuhauser, H. K., Radtke, A., von Brevern, M., Feldmann, M., Lezius, F., Ziese,
T., et al. (2006). Migrainous vertigo: prevalence and impact on quality of life.
Neurology 67, 1028–1033. doi: 10.1212/01.wnl.0000237539.09942.06
Oh, A. K., Lee, H., Jen, J. C., Corona, S., Jacobson, K. M., and Baloh, R. W.
(2001). Familial benign recurrent vertigo. Am. J. Med. Genet. 100, 287–291.
doi: 10.1002/ajmg.1294
Oliveira, C. A., Bezerra, R. L., Araújo, M. F., Almeida, V. F., and Messias, C. I.
(1997). Menière’s syndrome and migraine: incidence in one family. Ann. Otol.
Rhinol. Laryngol. 106, 823–829. doi: 10.1177/000348949710601004
Peddareddygari, L. R., Kramer, P. D., Hanna, P. A., Levenstien, M. A., and Grewal,
R. P. (2019). Genetic analysis of a large family with migraine, vertigo, motion
sickness. Can. J. Neurol. Sci. 46, 512–517. doi: 10.1017/cjn.2019.64
Power, L., Shute, W., McOwan, B., Murray, K., and Szmulewicz, D. (2018). Clinical
characteristics and treatment choice in vestibular migraine. J. Clin. Neurosci.
52, 50–53. doi: 10.1016/j.jocn.2018.02.020
Prodan Žitnik, I., Cerne, D., Mancini I, Simi, L., Pazzagli, M., Di Resta,
C., et al. (2018). Personalized laboratory medicine: a patient-centered
future approach. Clin. Chem. Lab. Med. 56, 1981–1991. doi: 10.1515/cclm-
2018-0181
Rainero, I., Vacca, A., Govone, F., Gai, A., Pinessi, L., and Rubino, E. (2019).
Migraine: genetic variants and clinical phenotypes. Curr. Med. Chem. 26,
6207–6221. doi: 10.2174/0929867325666180719120215
Requena, T., Espinosa-Sanchez, J., and Lopez-Escamez, J. (2014b). Genetics of
dizziness: cerebellar and vestibular disorders. Curr. Opin. Neurol. 27, 98–104.
doi: 10.1097/WCO.0000000000000053
Requena, T., Espinosa-Sanchez, J. M., Cabrera, S., Trinidad, G., Soto-Varela, A.,
Santos-Perez, S., et al. (2014a). Familial clustering and genetic heterogeneity in
Meniere’s disease. Clin. Genet. 85, 245–252. doi: 10.1111/cge.12150
Russell, M. B., Iselius, L., and Olesen, J. (1996). Migraine without aura
and migraine with aura are inherited disorders. Cephalalgia 16, 305–309.
doi: 10.1046/j.1468-2982.1996.1605305.x
Stewart, W. F., Bigal, M. E., Kolodner, K., Dowson, A., Liberman, J.
N., and Lipton, R. B. (2006). Familial risk of migraine: variation by
proband age at onset and headache severity. Neurology 66, 344–348.
doi: 10.1212/01.wnl.0000196640.71600.00
Sutherland, H. G., and Griffiths, L. R. (2017). Genetics of migraine: insights
into the molecular basis of migraine disorders. Headache 57, 537–569.
doi: 10.1111/head.13053
Teggi, R., Colombo, B., Albera, R., Asprella Libonati, G., Balzanelli, C., Batuecas
Caletrio, A., et al. (2018). Clinical features, familial history, and migraine
precursors in patients with definite vestibular migraine: the VM-phenotypes
projects. Headache 58, 534–544. doi: 10.1111/head.13240
Tungvachirakul, V., Lisnichuk, H., and O’Leary, S. (2014). Epidemiology of
vestibular vertigo in a neuro-otology clinic population in Thailand. J. Laryngol.
Otol. 128, S31–S38. doi: 10.1017/S0022215113003484
Ulrich, V., Gervil, M., Kyvik, K. O., Olesen, J., and Russell, M. B. (1999). The
inheritance of migraine with aura estimated by means of structural equation
modelling. J. Med. Genet. 36, 225–227.
Uneri, A. (2004). Migraine and benign paroxysmal positional vertigo:
an outcome study of 476 patients. Ear Nose Throat J. 83, 814–815.
doi: 10.1177/014556130408301211
Van Ombergen, A., Van Rompaey, V., Van De Heyning, P., and Wuyts, F.
(2015). Vestibular migraine in an otolaryngology clinic: prevalence, associated
symptoms, and prophylactic medication effectiveness. Otol. Neurotol. 36,
133–138. doi: 10.1097/MAO.0000000000000596
von Brevern, M., Radtke, A., Lezius, F., Feldmann, M., Ziese, T., Lempert,
T., et al. (2007). Epidemiology of benign paroxysmal positional vertigo:
a population based study. J. Neurol. Neurosurg. Psychiatr. 78, 710–715.
doi: 10.1136/jnnp.2006.100420
von Brevern, M., Ta, N., Shankar, A., Wiste, A., Siegel, A., Radtke, A.,
et al. (2006). Migrainous vertigo: mutation analysis of the candidate genes
CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache 46, 1136–1141.
doi: 10.1111/j.1526-4610.2006.00504.x
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